{"id":"W2900369580","doi":"10.1182/blood-2018-99-110858","title":"Ravulizumab (ALXN1210) Versus Eculizumab in Adults with Paroxysmal Nocturnal Hemoglobinuria: Pharmacokinetics and Pharmacodynamics Observed in Two Phase 3 Randomized, Multicenter Studies","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Pharmacodynamics; Surrogate endpoint; Clinical endpoint; Internal medicine; Pharmacokinetics; Dosing; Gastroenterology; Phases of clinical research; Clinical trial; Pharmacology; Immunology; Antibody; Complement system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004232537,0.0004099371,0.0008900978,0.0002099585,0.0001218165,0.00002662153,0.0002702405,0.00008369049,0.0002641767],"category_scores_gemma":[0.0001779276,0.0003286368,0.00009916855,0.0002324265,0.0007005854,0.0001477635,0.0002006248,0.0003133041,0.0000471453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009347778,"about_ca_system_score_gemma":0.00007330547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001813652,"about_ca_topic_score_gemma":0.001236613,"domain_scores_codex":[0.9973444,0.0006475365,0.0007483154,0.000559478,0.00009572364,0.0006044884],"domain_scores_gemma":[0.9987108,0.0005385645,0.0002530344,0.0002725934,0.0001637254,0.00006125575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9005599,0.006396818,0.03996966,0.0006539394,0.004367267,0.0006081827,0.007940791,0.00006601358,0.03530734,0.0001657123,0.0007340317,0.003230336],"study_design_scores_gemma":[0.9783807,0.0007272122,0.001427081,0.0005102265,0.0007488641,0.00009923799,0.001392792,0.0007747455,0.01495933,0.00002530819,0.0005002784,0.0004541607],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870789,0.009915684,0.00002110132,0.0001201651,0.001008202,0.001466625,0.0001073279,0.00006160216,0.0002203606],"genre_scores_gemma":[0.9986333,0.0005176341,0.0002443556,0.00008763961,0.0001344107,0.0001986512,0.0000893649,0.00003271835,0.00006192805],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07782084,"threshold_uncertainty_score":0.9999166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02722015948553447,"score_gpt":0.3312612590890698,"score_spread":0.3040410996035354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}